- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Jazz Pharmaceuticals Plc+ Add to Watchlist
JAZZ:US147.9500 USD 2.0800 1.43%
As of 17:20:00 ET on 07/23/2014.
Company Profile for Jazz Pharmaceuticals Plc (JAZZ)
Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.
Jazz Pharmaceuticals Plc
Key Executives for Jazz Pharmaceuticals Plc (JAZZ)
|Bruce C CozaddChairman/CEO/Co-Founder||Russell J CoxExec VP/COO|
|Suzanne Sawochka HooperExec VP/General Counsel||Jeffrey K Tobias "Jeff"Exec VP:Research & Development|
|Fintan KeeganExec VP:Technical Operations||Matthew YoungSenior VP/CFO|
|Karen J WilsonSenior VP:Finance||Laurie Hurley MackenzieVP:Corporate Affairs|
|Kathee LittrellVP:Investor Relations|